Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Fibrosis-memory is mediated by IL-3–producing T cells and drives progression of fibrosis
Simone Buchtler, Antje Frühauf, Sophia Neumayer, Kathrin Schmidbauer, Yvonne Talke, Frederike Winter-Köhler, Saidou Balam, Karin Landgraf, Claudia Gebhard, Michael Rehli, Florian Volker Schlieckau, Maria Beck, Florian Günther, Martin Fleck, Kerstin Renner, Matthias Mack
Simone Buchtler, Antje Frühauf, Sophia Neumayer, Kathrin Schmidbauer, Yvonne Talke, Frederike Winter-Köhler, Saidou Balam, Karin Landgraf, Claudia Gebhard, Michael Rehli, Florian Volker Schlieckau, Maria Beck, Florian Günther, Martin Fleck, Kerstin Renner, Matthias Mack
View: Text | PDF
Research Article Immunology Nephrology

Fibrosis-memory is mediated by IL-3–producing T cells and drives progression of fibrosis

  • Text
  • PDF
Abstract

Repetitive injuries are an important trigger of progressive fibrosis. To study if repetitive injuries induce an accelerated profibrotic process, also called “fibrosis-memory,” we established an experimental system with two consecutive, clearly separated insults in a model of renal fibrosis with reversible and irreversible unilateral ureteral obstruction. We found that a preceding fibrotic event of one kidney markedly enhanced subsequent development of fibrosis in the contralateral kidney. Aggravation of fibrosis during the second insult was dependent on memory CD4+ T cells. T cell depletion abrogated the fibrosis-memory effect, while adoptive transfer of memory T cells from fibrotic mice enhanced fibrosis in the recipients. Moreover, IL-3 production by memory CD4+ T cells was essential for aggravation of fibrosis in memory situations. In patients with systemic sclerosis, IL-3 expression by T cells was markedly increased, especially after a long disease duration accompanied by involvement of internal organs. In summary, our data identify IL-3–mediated fibrosis-memory as an important driver of progressive fibrosis.

Authors

Simone Buchtler, Antje Frühauf, Sophia Neumayer, Kathrin Schmidbauer, Yvonne Talke, Frederike Winter-Köhler, Saidou Balam, Karin Landgraf, Claudia Gebhard, Michael Rehli, Florian Volker Schlieckau, Maria Beck, Florian Günther, Martin Fleck, Kerstin Renner, Matthias Mack

×

Figure 6

Retrieval and adoptive transfer of fibrosis-memory is dependent on T cell–derived IL-3.

Options: View larger image (or click on image) Download as PowerPoint
Retrieval and adoptive transfer of fibrosis-memory is dependent on T cel...
(A) RUUO of the right kidney (day 0–6, first insult) followed by UUO of the left kidney (day 16–22, second insult). Treatment with anti–IL-3 (n = 20) or isotype control antibody (n = 18; 4 pooled experiments, same controls as in Figure 2A) from day 15–21. Analysis of the left UUO kidneys on day 22. (B) WT or IL-3–KO mice underwent RUUO of the right kidney (day 0–6, first insult) or remained naive (Ø). All mice then underwent UUO of the left kidney (day 16–22). Analysis of the left UUO kidneys on day 22. One experiment with n = 7, WT RUUO+UUO; 7, IL-3-KO RUUO+UUO; 6, WT UUO; and 7, IL-3-KO UUO. (C) Splenic CD62L–CD4+ or renal CD4+ T cells were purified from the spleens or fibrotic kidneys of RUUO+UUO donor mice (RUUO from day –18 to –12 and UUO of the same kidney from day –7 to 0). Medium, 4 × 106 splenic CD62L–CD4+ or 67,000 renal CD4+ T cells were injected into recipients on day 0. UUO in all recipients on day 0. Treatment with anti–IL-3 or an isotype control antibody (Ø) from day 0–6. Analysis of the recipient’s UUO kidneys on day 7. Single experiment with n = 8, no cell transfer; 5, no cell transfer and anti–IL-3; 7, transfer of CD62L- from spleen; 7, transfer of CD62L- from spleen and anti–IL-3; 3, transfer of CD4+ from UUO kidney; and 3, transfer of CD4+ from UUO kidney and anti–IL-3. (D) Splenic CD62L–CD4+ or renal CD4+ T cells were purified from the spleens or fibrotic kidneys of WT or IL-3–deficient (IL-3 KO) RUUO+UUO mice, as in C. Medium (Ø), 4 × 106 splenic CD62L–CD4+ or 116,000 renal CD4+ T cells were injected on day 0. UUO in all recipients on day 0. Analysis of the recipient’s UUO kidneys on day 7. Single experiment with n = 7, no cell transfer; 8, CD62L+ from spleen of WT; 7, CD62L+ from spleen of IL-3 KO; 5, CD62L+ from UUO-kidney of WT; and 8, CD62L+ from UUO-kidney of IL-3 KO. Data are represented as mean ± SEM. Unpaired 2-sided t test. *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts